Division of Endocrinology, Department of Clinical Medicine and Applied Biotechnologies, Polytechnic University of Marche, Torrette, Ancona, Italy.
J Endocrinol Invest. 2012 Jun;35(6):590-4. doi: 10.3275/8010. Epub 2011 Oct 4.
Fine-needle aspiration (FNA) of adrenal masses is a method currently indicated in lesions suspected of being extra-adrenal in origin; even though its diagnostic reliability has already been determined in many studies, few have used histological examination obtained after adrenalectomy for diagnostic confirmation.
To analyze the diagnostic performance of adrenal FNA in subjects with an available histological confirmation.
Fifty subjects (26 benign adrenal lesions, 9 primary malignant lesions, and 15 metastatic lesions) who had undergone ultrasound (US)-guided adrenal FNA and then adrenalectomy were re-analyzed retrospectively.
FNA guaranteed a sensitivity of 85.7% and a specificity of 100% in all subjects; after having divided the subjects into oncologic and non-oncologic groups, the sensitivity of the test in oncologic patients (100%) increased significantly compared to non-oncologic (57.1%) with no difference in specificity (100% in both groups). Considering also non-diagnostic samples in our analysis (no.=11; 22% of all samples studied), FNA correctly diagnosed malignancy only in 75% of the cases and benignancy only in 66.6%; however, even after including non-diagnostic samples, the percentage of correct malignancy diagnosis remained significantly higher in oncologic (93.3%) than in non-oncologic patients (44.4%) without significant statistical difference between the 2 groups regarding the percentage of correct benignancy diagnosis (respectively 100% and 63.6%).
Our study, based on histological confirmation, underlines the low discriminant value of US-guided adrenal FNA, though the method may have value in oncologic patients.
细针抽吸(FNA)用于怀疑肾上腺外起源的肾上腺肿块;尽管其诊断可靠性已在许多研究中得到确定,但很少有研究使用肾上腺切除术后获得的组织学检查进行诊断确认。
分析有组织学确认的肾上腺 FNA 的诊断性能。
回顾性分析了 50 名接受超声(US)引导下肾上腺 FNA 后行肾上腺切除术的受试者(26 例良性肾上腺病变、9 例原发性恶性病变和 15 例转移性病变)。
FNA 在所有受试者中的敏感性为 85.7%,特异性为 100%;将受试者分为肿瘤和非肿瘤组后,肿瘤患者的检测敏感性(100%)显著高于非肿瘤患者(57.1%),特异性(两组均为 100%)无差异。在我们的分析中还考虑了非诊断性样本(n=11;所有研究样本的 22%),FNA 仅正确诊断出恶性肿瘤的 75%和良性肿瘤的 66.6%;然而,即使包括非诊断性样本,肿瘤患者(93.3%)的恶性肿瘤诊断正确率仍明显高于非肿瘤患者(44.4%),但两组的良性肿瘤诊断正确率无统计学差异(分别为 100%和 63.6%)。
我们的研究基于组织学确认,强调了 US 引导下肾上腺 FNA 的低鉴别价值,但该方法在肿瘤患者中可能具有价值。